Responses
GWICC Abstracts 2010
Clinical and research medicine: Cardiovascular clinical pharmaceutical research
e0352 Efficacy and safety of aliskiren in chinese patients with mild or moderate essential hypertension
Compose a Response to This Article
Other responses
No responses have been published for this article.